Home › Targets › TL1A

TL1A (2 companies · 8 programs)

Companies with an active program directed at TL1A.

Spyre Therapeutics, Inc. SYRE

SPY002 — Ulcerative Colitis Phase 2
SPY002 — Crohn's Disease Phase 2
SPY072 — Rheumatoid Arthritis Phase 2
SPY072 — Psoriatic Arthritis Phase 2
SPY072 — Axial Spondyloarthritis Phase 2
SPY120 — Ulcerative Colitis Phase 2
SPY230 — Ulcerative Colitis Phase 2

Absci Corporation ABSI

ABS-101 — Inflammatory Bowel Disease Phase 1